(Natural News) The American Association of Physicians and Surgeons (AAPS) is suing the U.S. Food and Drug Administration (FDA) for withholding from the public some 60 million doses of hydroxychloroquine (HCQ) that were donated by drug manufacturers to treat Wuhan coronavirus (COVID-19) patients.
Currently, these 60 million doses of HCQ are under strict lock and key at the Strategic National Stockpile because the FDA refuses to allow doctors to prescribe the drug to their ailing patients. Consequently, tens of thousands of Americans are needlessly suffering and dying from an illness that, quite frankly, is preventable.
Because the medical deep state eventually wants everyone to get vaccinated for the Wuhan coronavirus (COVID-19), HCQ must remain off-limits because its widespread use would quickly prove that there is no need for a vaccine (RELATED: Learn more about how green tea and zinc can help support a healthy, COVID-free lifestyle).
“[The FDA cares] more about [its] power over the HCQ Stockpile than the lives being lost daily without access to it,” the lawsuit against the FDA reads.
“[T]he injunction plaintiff seeks would irreversibly overturn the status quo, by compelling the government to disburse the hydroxychloroquine in the Stockpile – a step that, once taken, cannot be undone.”
The only thing that cannot be undone, the plaintiffs lament, is the “loss of life” that has come about due to the FDA playing politics with HCQ rather than simply doing the right thing to help sick people recover with this inexpensive, science-based remedy.
Up to 100,000 lives could be saved if the FDA stopped restricting hydroxychloroquine
According to Yale University professor Dr. Harvey Risch, somewhere between 50,000 and 100,000 lives could be saved from the Wuhan coronavirus (COVID-19) if only the FDA would repent of its sins by unleashing the HCQ Stockpile.
Keep in mind that HCQ was approved by the FDA as a safe and effective drug back in 1955 – almost 70 years ago – and only now is the agency suddenly claiming that the drug is no longer safe and effective. Even the U.S. Centers for Disease Control and Prevention (CDC) agrees that HCQ is safe and effective, so why is the drug still prohibited from being used to put an end to the plandemic?
The AAPS is calling on the 6th U.S. Circuit Court of Appeals to enjoin the FDA to “make available and distribute promptly, and for the benefit of the public holding valid prescriptions, the HCQ being stored in the [Strategic National Stockpile].”
The FDA insists that its decisions are not reviewable by a federal court, however the AAPS was quick to point out that, based on that view, the agency “could dump the entire HCQ Stockpile into the Potomac River and there would be no legal accountability.”
The suit was filed in response to the FDA’s refusal to approve HCQ for use in treating the Wuhan coronavirus (COVID-19), even after a clinical trial showed the drug to be a safe and effective remedy.
According to Dr. Jane Orient, executive director of the AAPS, the FDA “continues to obstruct the use of a long-established antimicrobial that can also be used in outpatients, to prevent the need for hospitalization.”
“Because of FDA’s negative statements about HCQ (hydroxychloroquine), patients are having great difficulty in obtaining HCQ,” she further points out, noting that a research team from the Henry Ford Health System in Detroit found that HCQ helped to bring about a 51 percent reduction in mortality among Wuhan coronavirus (COVID-19) patients treated at area hospitals.
“Without HCQ and zinc, by day six or seven the viral load explodes and then triggers an exaggerated inflammatory response,” adds Dr. Elizabeth Van Vliet, M.D., about how HCQ with zinc “works during the first five days to stop viral entry into our cells and to block the virus from multiplying.”
More of the latest news about the Wuhan coronavirus (COVID-19) plandemic can be found at Pandemic.news.
Sources for this article include: